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1601(Table 1). The low prevalence of Marfan syndrome and
hypertension amongst pregnant patients in our study
suggests that distinct effects of pregnancy are likely
and portend an independent risk for aortic dissection.
Histopathological ﬁndings within the aortic media
conﬁrm loss of normal corrugation of elastic ﬁbers
and fragmentation of reticulin ﬁbers in pregnancy (5).
We believe these changes occur in response to hor-
monal shifts during the latter trimesters of preg-
nancy, representing a unique substrate for aortic
dissection. Through the continued use of interna-
tional registries and multidisciplinary collaboration
amongst heart, vascular, and obstetrical teams, we
will be able to better deﬁne the risks of aortic
dissection in pregnancy.Neal Sawlani, MD
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Management Before Surgery
Aortic Dissection and Mortality Associated
With Pregnancy in the United StatesWe thank Dr. Aggarwal and Dr. Raymond for their
comments on our paper (1). We agree that patients
with aortic dissections often present to hospitals that
are not equipped to provide immediate aortic surgery.Pre-operative medical management is important but
should not delay transfer for surgery. In IRAD (Inter-
national Registry of Acute Aortic Dissection), 73% of
patients presenting with type A dissection were
transferred from nontertiary care facilities, and pre-
sentation at a nontertiary care hospital was associated
with delayed surgery (p < 0.001) (2).
In the IRAD database, the median time from arrival
to diagnosis was 4.3 h and from diagnosis to surgery
another 4.3 h. Dr. Aggarwal and Dr. Raymond report a
median interval of 87 min, but started the clock for
transfer to their institution when the aortic transfer
team was activated, rather than when the patients
presented to the emergency department (3). Of the
263 patients transferred, only 40% (104) had type A
dissections (95 had type B dissections, 14 had aneu-
rysms without dissection, 4 had penetrating aortic
ulcers, 18 had intramural hematomas, and 28 had no
major aortic pathology). The impact of pre-hospital
treatment seems modest: a mean 10 mm Hg
decrease in blood pressure and a 3 beats per min
reduction in heart rate among all transferred patients,
not only those with type A dissections.
We commend Dr. Aggarwal and Dr. Raymond for
the steps taken at their institution to streamline the
transfer of patients with suspected aortic dissection.
At the Cleveland Clinic, the transfer of patients
directly to the cardiac care unit from 84 regional
medical centers is facilitated by an organized aortic
network, telephone hotline, and transfer under the
watchful eyes of specially trained nurse practitioners
and paramedics in contact with cardiovascular
intensivists, and by modes of transportation that
include ambulances, helicopters, and jet planes.
Although few institutions have this infrastructure,
and costs can be prohibitive, elements of this program
could likely be replicated in other centers.
Dr. Sawlani and colleagues present unpublished
results from their examination of data culled from the
Nationwide Inpatient Sample (NIS), which includes
records from 20% of hospital discharges across the
United States. They identiﬁed 44 cases of aortic dis-
section during pregnancy from among 41,044 dis-
sections. This is consistent with the IRAD ﬁnding that
dissection during pregnancy is rare. In the IRAD
database, only 2 of 346 women who had dissections
were pregnant. Even patients with Marfan syndrome
were more likely to dissect outside of pregnancy than
during pregnancy (4).
In the sample from Dr. Sawlami and colleagues,
patients who experienced dissection during preg-
nancy were younger, less likely to be hypertensive,
and more likely to have Marfan syndrome than their
nonpregnant counterparts. Similarly, in the IRAD
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1602database, younger patients (age <40 years) were less
likely to have hypertension and were more likely to
have Marfan syndrome, bicuspid aortic valve, and
prior cardiac surgery (p < 0.05), all risk factors for
dissection (5).
On the basis of the limited data presented, it is
difﬁcult to draw the broad conclusion that pregnancy
is an independent risk factor for dissection. It would
be helpful to know more about the methods used,
including how the statistical analysis was conducted,
and to know the prevalence for dissection risk factors
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CHA2DS2-VASc Score?Oral anticoagulation therapy for stroke prevention is
the cornerstone of atrial ﬁbrillation (AF) manage-
ment. Current international guidelines focus on ac-
curate identiﬁcation of “truly low-risk” patients in
order to exclude them from such therapy, reserving
it for those with immediate or high stroke risk.
Accordingly, the CHA2DS2-VASc score has been rec-
ommended as the standard means of stroke risk
stratiﬁcation. With the exception of those with aCHA2DS2-VASc score of 0, that is an annual stroke risk
of 0.7%/year, oral anticoagulation therapy should be
considered/recommended (Class I, Level of Evidence:
A, and Class IIa, Level of Evidence: A).
In a recently published article in the Journal, Chao
et al. (1) compared the performance of the CHA2DS2-
VASc score with that of the ATRIA (Anticoagulation
and Risk Factors in Atrial Fibrillation) score in the
prediction of stroke in a large contemporary Chinese
population with AF in Taiwan. Like previous large
validation cohorts from Western Europe (2,3) and
North America (4), stroke risk in the Taiwan cohort
increased with increasing CHA2DS2-VASc score.
Nonetheless, a striking feature of the Taiwan cohort
was that although patients with a high CHA2DS2-VASc
score had a comparable stroke risk with previous
Caucasian series, the annual stroke risk in those with
a low CHA2DS2-VASc score was 2- to 3-fold higher
(Figure 1). This is consistent with our recent ﬁnding in
a hospital-based Chinese cohort in Hong Kong (5). In
addition, exploration of data from recent randomized
controlled trials of non-vitamin K oral anticoagulants
(NOACs) for stroke prevention in AF, revealed that
despite comparable CHA2DS2-VASc scores, the annual
stroke risk amongst Asian AF patients is likewise
higher, up to 2.5-fold that of comparable non-Asian
individuals prescribed the same treatment. These
ﬁndings concur with the evidence that globally,
China and other Asian countries are amongst the
countries with the highest incidence of stroke. These
data inevitably raise the possibility that ethnicity is
an important risk factor with an additive role that can
improve risk stratiﬁcation scores in AF. One simple
and straightforward way to modify the CHA2DS2-
VASc score for the Chinese population with a high
baseline stroke risk is to add one more “C” (“C” for
Chinese) to the score, i.e., C2HA2DS2-VASc score.
Although such an approach may enable recalibra-
tion of the stroke risk stratiﬁcation for Chinese AF
patients and align with data derived from previous
Caucasian series, attributing the observed difference
in stroke risk to ethnicity alone may be an over-
simpliﬁcation. This difference in stroke risk between
Chinese and previous Caucasian cohorts, as stratiﬁed
by the CHA2DS2-VASc score, may indicate a missing
component risk factor in the score that contributes to
stroke in Chinese or Asians. Examples may include
factors such as age 55 to 64 years, undiagnosed and/or
suboptimally treated hypertension, and hyperthy-
roidism. Another plausible explanation for the high
stroke risk in Chinese AF patients is related to the
high prevalence of noncardioembolic stroke in Chi-
nese. For instance, intracranial atherosclerosis ac-
counts for one-third to one-half of strokes and 45% of
